EFFECT OF HEMODIALYSIS ON METOCLOPRAMIDE KINETICS IN PATIENTS WITH SEVERE RENAL-FAILURE

被引：6

作者：

WRIGHT, MR

AXELSON, JE

RURAK, DW

MCERLANE, B

MCMORLAND, GH

ONGLEY, RC

TAM, YK

PRICE, JDE

机构：

[1] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,DIV PHARMACEUT & BIOPHARMACEUT,2146 E MALL,VANCOUVER V6T 1W5,BC,CANADA

[2] UNIV BRITISH COLUMBIA,DEPT ANAESTHESIOL,VANCOUVER V6T 1W5,BC,CANADA

[3] UNIV BRITISH COLUMBIA,DIV DERMATOL,VANCOUVER V6T 1W5,BC,CANADA

[4] UNIV BRITISH COLUMBIA,DEPT OBSTET & GYNAECOL,VANCOUVER V6T 1W5,BC,CANADA

[5] UNIV BRITISH COLUMBIA,DIV NEPHROL,VANCOUVER V6T 1W5,BC,CANADA

[6] UNIV BRITISH COLUMBIA,FAC MED,VANCOUVER V6T 1W5,BC,CANADA

[7] UNIV ALBERTA,FAC PHARM & PHARMACEUT SCI,EDMONTON T6G 2E1,ALBERTA,CANADA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 26卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.1988.tb03408.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：474 / 477

页数：4

共 18 条

[1] THE PHARMACOKINETICS OF SINGLE DOSES OF METOCLOPRAMIDE IN RENAL-FAILURE [J].

BATEMAN, DN ;

GOKAL, R ;

DODD, TRP ;

BLAIN, PG .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (06) :437-441

[2]

BATEMAN DN, 1979, LANCET, V1, P166

[3]

BATEMAN DN, 1980, LANCET, V1, P982

[4] CLINICAL PHARMACOKINETICS OF METOCLOPRAMIDE [J].

BATEMAN, DN .

CLINICAL PHARMACOKINETICS, 1983, 8 (06) :523-529

[5] THE PHARMACOKINETICS OF METOCLOPRAMIDE IN MAN WITH OBSERVATIONS IN THE DOG [J].

BATEMAN, DN ;

KAHN, C ;

DAVIES, DS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (04) :371-377

[6]

BIANCHETTI G, 1976, Clinical Pharmacokinetics, V1, P373, DOI 10.2165/00003088-197601050-00004

[7]

CARALPS A, 1979, LANCET, V1, P554

[8]

GIBALDI M, 1982, PHARMACOKINETICS, P83

[9]

JONES C T, 1968, New Zealand Medical Journal, V68, P388

[10] DRUG-THERAPY IN PATIENTS UNDERGOING HEMODIALYSIS - CLINICAL PHARMACOKINETIC CONSIDERATIONS [J].

LEE, CSC ;

MARBURY, TC .

CLINICAL PHARMACOKINETICS, 1984, 9 (01) :42-66

← 1 2 →